company background image
FME logo

Fresenius Medical Care SWX:FME Stock Report

Last Price

CHF 81.20

Market Cap

CHF 9.4b

7D

0%

1Y

0%

Updated

20 Aug, 2024

Data

Company Financials +

Fresenius Medical Care AG

SWX:FME Stock Report

Market Cap: CHF 9.4b

FME Stock Overview

Provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. More details

FME fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance1/6
Financial Health4/6
Dividends5/6

Rewards

Trading at 75.3% below our estimate of its fair value

Earnings are forecast to grow 22.2% per year

Pays a reliable dividend of 3.53%

Trading at good value compared to peers and industry

Risk Analysis

Has a high level of debt


My Notes

Capture your thoughts, links and company narrative

Fresenius Medical Care AG Competitors

Galenica

SWX:GALE

CHF 3.7b

Sonova Holding

SWX:SOON

CHF 17.7b

Straumann Holding

SWX:STMN

CHF 18.9b

Ypsomed Holding

SWX:YPSN

CHF 5.0b

Price History & Performance

Summary of share price highs, lows and changes for Fresenius Medical Care
Historical stock prices
Current Share Price€81.20
52 Week High€0
52 Week Low€0
Beta0.86
1 Month Change0%
3 Month Change0%
1 Year Change0%
3 Year Change0%
5 Year Change7.86%
Change since IPO1.75%

Recent News & Updates

Recent updates

Shareholder Returns

FMECH HealthcareCH Market
7D0%-1.1%-0.5%
1Y0%4.0%2.8%

Return vs Industry: FME exceeded the Swiss Healthcare industry which returned -2.6% over the past year.

Return vs Market: FME underperformed the Swiss Market which returned 9.2% over the past year.

Price Volatility

Is FME's price volatile compared to industry and market?
FME volatility
FME Average Weekly Movement0%
Healthcare Industry Average Movement4.2%
Market Average Movement3.3%
10% most volatile stocks in CH Market7.4%
10% least volatile stocks in CH Market1.6%

Stable Share Price: FME has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine FME's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1996113,639Helen Gizawww.freseniusmedicalcare.com

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products.

Fresenius Medical Care AG Fundamentals Summary

How do Fresenius Medical Care's earnings and revenue compare to its market cap?
FME fundamental statistics
Market capCHF 9.41b
Earnings (TTM)CHF 504.38m
Revenue (TTM)CHF 18.47b

18.7x

P/E Ratio

0.5x

P/S Ratio

Is FME overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
FME income statement (TTM)
Revenue€19.42b
Cost of Revenue€14.50b
Gross Profit€4.92b
Other Expenses€4.39b
Earnings€530.26m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Nov 05, 2024

Earnings per share (EPS)1.81
Gross Margin25.33%
Net Profit Margin2.73%
Debt/Equity Ratio50.6%

How did FME perform over the long term?

See historical performance and comparison

Dividends

3.5%

Current Dividend Yield

66%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/08/20 09:27
End of Day Share Price 2024/08/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Fresenius Medical Care AG is covered by 59 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Martin SchneeAlphaValue
Brian WilliamsAvondale Partners
Olav ZilianBaader Helvea Equity Research